Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino?

GATE 2027 Biotechnology syllabus has been revised with major additions in biology, genetics, plant biotechnology and ...

Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...

Biotechnology investors remain confident in the sector's outlook even after a major comeback this year — and they're picking ...

Vir Biotechnology has partnered with Astellas Pharma to develop VIR-5500, its masked PSMA-targeting T-cell engager for ...

Frontiers in Biotechnology and Bioengineering is launching a special issue titled – "False Positives and Negative Results in Protein Sciences" within the ...

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

See the U.S. News rankings for Biotechnology and Applied Microbiology among the top universities in United States. Compare the academic programs at the world's best universities.

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Updated Phase 1 dose-escalation data (n=58) show VIR-5500 monotherapy has a favorable safety profile and was well tolerated with no dose-limiting toxicities observed to date - Dose-dependent anti-tumo ...